Skip to main content
Mukka Proteins Limited logo

Mukka Proteins Limited — Investor Relations & Filings

Ticker · MUKKA ISIN · INE0CG401037 LEI · 3358001F6BWKSFSZ2U02 BSE.NS Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2024-09-27 Regulatory Filings
Country IN India
Listing BSE.NS MUKKA

About Mukka Proteins Limited

https://mukkaproteins.com/

Mukka Proteins Limited specializes in the manufacture and supply of high-quality fish meal, fish oil, and fish soluble paste. The company serves as a critical supplier to the global aquafeed, poultry feed, and pet food sectors. Its core operations involve processing raw fish into nutrient-dense protein sources and essential fatty acids, including Omega-3. The product portfolio includes steam-dried fish meal and high-grade fish oil used in specialized animal nutrition formulations. Mukka Proteins maintains a robust supply chain and utilizes advanced processing technologies to ensure product consistency and nutritional integrity. The company caters to both domestic and international markets, positioning itself as a key provider of sustainable marine protein ingredients for the livestock and aquaculture sectors.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2024-09-27 English
Appointment
Board/Management Information Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the re-appointment of the statutory auditors at the 14th Annual General Meeting held on 26th September 2024. It includes details about the auditor's term and profile but does not contain any financial statements or detailed audit reports. The document is relatively short (3975 characters) and serves as an announcement of a corporate governance event rather than a full audit report or annual report. Therefore, it fits best under the category of Board/Management Information (MANG), as it relates to the appointment of auditors, which is a management/board-level disclosure.
2024-09-26 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled 'Proceedings of 14th Annual General Meeting held on 26th September 2024' and contains a detailed summary of the AGM proceedings including attendance, agenda items, resolutions passed, and Q&A session. It explicitly states it is a summary of the AGM proceedings and not the minutes or the full report. It also mentions that voting results will be separately intimated. The document is about the meeting itself and the summary of what transpired during the AGM, which fits the category of AGM Information (AGM-R). The document length is 8786 characters, which is substantial but the content is clearly a meeting summary, not a full annual report or financial statement. Therefore, the correct classification is AGM Information (AGM-R).
2024-09-26 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter dated 04-09-2024 from the Company Secretary & Compliance Officer of Mukka Proteins Limited addressing clarifications related to financial results submitted to the stock exchange. It discusses regulatory compliance issues such as delay in disclosure of board meeting outcomes and differences in financial result formats (PDF vs XBRL). The letter references SEBI (LODR) Regulations and SEBI circulars, indicating it is a regulatory communication rather than a full financial report. The document length is short (2286 characters) and it does not contain actual financial statements or detailed financial data, but rather explanations and assurances regarding regulatory compliance and disclosures. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2024-09-06 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document contains a notice of the 14th Annual General Meeting (AGM) of Mukka Proteins Limited, including details about the meeting date, e-voting information, and references to the Annual Report for the financial year 2023-24. It also mentions that the Notice and Annual Report have been sent electronically to members and are available on the company's and stock exchanges' websites. The document is primarily a formal announcement and notice related to the AGM and e-voting, not the full Annual Report itself. The length is about 15,000 characters, but the content is focused on the AGM notice and related procedural information rather than detailed financial statements or management discussion. Therefore, this document fits the category of AGM Information (AGM-R) rather than the Annual Report (10-K) or Report Publication Announcement (RPA).
2024-09-04 English
Shareholders meeting
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2023-24' and includes detailed sections such as Company Overview, Statutory Reports, Financial Statements, Notice of AGM, Board of Directors, Awards, Message from Managing Director, Corporate Information, and Board's Report. It references the financial year ended 31st March 2024 and contains comprehensive content typical of a full annual report, including audited standalone and consolidated financial statements. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. Therefore, this document fits the definition of an Annual Report (10-K). FY 2024
2024-09-03 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.